Rare diseases
Investigational molecules
Locations
293 conditions with trials, the busiest first
1 664 trials across Europe, recruiting first
Study on the Effectiveness and Safety of Frexalimab and Teriflunomide in Adults with Relapsing Multiple Sclerosis
AustriaStudy on the Effects of Cenerimod for Adults with Moderate to Severe Systemic Lupus Erythematosus
BulgariaStudy on the Safety and Effectiveness of Upadacitinib and Dupilumab for Children Aged 2 to 12 with Moderate to Severe Atopic Dermatitis
AustriaStudy on the Safety and Effects of EryDex with Dexamethasone Sodium Phosphate for Patients with Ataxia Telangiectasia
DenmarkStudy on Long-term Safety and Effects of Efgartigimod PH20 SC for Adults with Bullous Pemphigoid
BulgariaStudy on the Effectiveness and Safety of Cenerimod for Adults with Moderate to Severe Systemic Lupus Erythematosus
CzechiaStudy on Ixekizumab for Preserving Insulin Production in Newly Diagnosed Type 1 Diabetes Patients
SwedenStudy on Stopping Infliximab, Methotrexate, and Azathioprine in Patients with Sarcoidosis in Remission
FranceStudy on Reducing Asthma Medication with Tezepelumab in Patients Aged 12 to 80 with Severe Asthma
BelgiumStudy on the Safety and Tolerability of VRDN-001 for Patients with Thyroid Eye Disease
FranceStudy on Guselkumab for Healing in Crohn's Disease Patients
BelgiumStudy of Inhaled Molgramostim for Adults with Autoimmune Pulmonary Alveolar Proteinosis
BelgiumThe therapies tested most often in Immune system disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
